SOFTHALE N.V.

Whilst major developments have occurred in the treatment of patients with respiratory disease, there is an increasing unmet need for both novel treatments and high-quality, affordable generic versions of inhaled products that have an established safety and efficacy profile. Our respiratory team is committed and passionate about delivering both... Our respiratory team has developed a next-generation, proprietary soft-mist inhalation platform device, the Softhaler®, which uses differentiated technology to deliver propellant-free liquid-based formulations to the lung... Our core team is made up of a multicultural international group of highly experienced individuals with life sciences and technology-centred backgrounds, all with a mutual passion and ambition for creating something different.

Primary location: London United Kingdom